This company has been marked as potentially delisted and may not be actively trading. XORTX Therapeutics (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX vs. SCNX, NERV, LPCN, BLRX, PRPH, TXMD, APM, MRKR, BIVI, and LYRAShould you be buying XORTX Therapeutics stock or one of its competitors? The main competitors of XORTX Therapeutics include Scienture (SCNX), Minerva Neurosciences (NERV), Lipocine (LPCN), BioLineRx (BLRX), ProPhase Labs (PRPH), TherapeuticsMD (TXMD), Aptorum Group (APM), Marker Therapeutics (MRKR), BioVie (BIVI), and Lyra Therapeutics (LYRA). These companies are all part of the "med - drugs" industry. XORTX Therapeutics vs. Its Competitors Scienture Minerva Neurosciences Lipocine BioLineRx ProPhase Labs TherapeuticsMD Aptorum Group Marker Therapeutics BioVie Lyra Therapeutics XORTX Therapeutics (NASDAQ:XRTX) and Scienture (NASDAQ:SCNX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Is XRTX or SCNX more profitable? XORTX Therapeutics has a net margin of 0.00% compared to Scienture's net margin of -10,364.22%. Scienture's return on equity of -24.47% beat XORTX Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets XORTX TherapeuticsN/A -73.46% -53.04% Scienture -10,364.22%-24.47%-19.30% Does the media prefer XRTX or SCNX? In the previous week, XORTX Therapeutics had 6 more articles in the media than Scienture. MarketBeat recorded 6 mentions for XORTX Therapeutics and 0 mentions for Scienture. XORTX Therapeutics' average media sentiment score of 0.00 equaled Scienture'saverage media sentiment score. Company Overall Sentiment XORTX Therapeutics Neutral Scienture Neutral Which has higher earnings & valuation, XRTX or SCNX? Scienture has higher revenue and earnings than XORTX Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXORTX TherapeuticsN/AN/A-$3.31M-$1.35-0.61Scienture$140K131.35$9.07MN/AN/A Do insiders & institutionals have more ownership in XRTX or SCNX? 0.2% of XORTX Therapeutics shares are owned by institutional investors. Comparatively, 5.7% of Scienture shares are owned by institutional investors. 6.9% of XORTX Therapeutics shares are owned by insiders. Comparatively, 49.7% of Scienture shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, XRTX or SCNX? XORTX Therapeutics has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Comparatively, Scienture has a beta of 3.06, indicating that its stock price is 206% more volatile than the S&P 500. SummaryScienture beats XORTX Therapeutics on 7 of the 9 factors compared between the two stocks. Get XORTX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXORTX TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.30M$2.61B$5.82B$9.94BDividend YieldN/A50.05%6.70%4.53%P/E RatioN/A23.1476.2126.11Price / SalesN/A751.14557.45121.74Price / CashN/A26.7025.7029.11Price / Book0.945.5011.486.09Net Income-$3.31M$32.95M$3.29B$266.19M XORTX Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXORTX Therapeutics0.225 of 5 stars$0.83+1.9%N/A-58.8%$4.30MN/A0.00N/ANews CoverageGap UpSCNXScientureN/A$1.05+0.9%N/AN/A$16.86M$140K0.00N/ANERVMinerva Neurosciences3.4481 of 5 stars$2.40+0.2%$5.00+108.8%-10.0%$16.74MN/A1.629Positive NewsLPCNLipocine3.2799 of 5 stars$3.06-1.3%$9.00+194.1%-21.0%$16.71M$4.21M-3.5410News CoverageGap DownBLRXBioLineRx2.2584 of 5 stars$3.79+4.8%$26.00+586.9%-85.0%$16.14M$17.25M-0.4340PRPHProPhase Labs0.2828 of 5 stars$0.34-1.2%N/A-87.1%$14.08M$5.59M-0.27130Short Interest ↑TXMDTherapeuticsMD0.2253 of 5 stars$1.14+1.2%N/A-37.6%$13.13M$1.76M0.00420APMAptorum Group1.9792 of 5 stars$2.43-2.7%N/A-38.7%$13.05M$430K0.0030News CoverageShort Interest ↓Gap DownMRKRMarker Therapeutics4.2055 of 5 stars$0.97-2.6%$13.17+1,251.8%-69.6%$12.60M$6.59M-0.7160Positive NewsShort Interest ↓BIVIBioVie0.3483 of 5 stars$1.62+2.2%N/A-93.0%$12.16MN/A-0.0210LYRALyra Therapeutics2.3257 of 5 stars$7.11-1.1%$100.00+1,306.1%-49.8%$11.69M$1.53M-0.2550 Related Companies and Tools Related Companies SCNX Alternatives NERV Alternatives LPCN Alternatives BLRX Alternatives PRPH Alternatives TXMD Alternatives APM Alternatives MRKR Alternatives BIVI Alternatives LYRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XRTX) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XORTX Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XORTX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XRTX Stock Alerts